Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Optimizing diagnostic tools and outcomes evaluation for t(9;22)-positive leukemias in pediatric LMIC patients (Bukhari SI et al. Cancer Invest, January 2025)

Optimizing diagnostic tools and outcomes evaluation for t(9;22)-positive leukemias in pediatric low middle-income country (LMIC) patients
Bukhari SI et al. Cancer Invest, January 2025 (epub ahead of print)

 

 

 

 

Growth retardation and adult height in pediatric patients with chronic-phase CML treated with TKIs (Shima H et al. Leukemia, Dec 2024)

Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
Shima H et al. Leukemia, December 2024 (epub ahead of print)

 

 

 

 

Clinical characteristics and outcomes of CML in adolescents and young adults (Al Rabi K et al. Clin Lymphoma Myeloma Leuk, Oct 2024)

Clinical characteristics and outcomes of CML in adolescents and young adults
Al Rabi K et al. Clin Lymphoma Myeloma Leuk, Oct 2024

 

 

 

 

Treatment-free remissions in children with CML: A prospective study from the Tata Memorial Hospital (TMA) Pediatric CML cohort (Roy Moulik N et al. Am J Hematol, Nov. 2024)

Treatment-free remissions in children with chronic myeloid leukemia (CML):
A prospective study from the Tata Memorial Hospital (TMA) Pediatric CML (pCML) cohort
Roy Moulik N et al. Am J Hematol, November 2024 (epub ahead of print) – open access publication

 

 

 

 

A high proportion of germline variants in pediatric chronic myeloid leukemia in pediatric chronic myeloid leukemia (Krumbold M et al. Mol Cancer, Sept 2024)

A high proportion of germline variants in pediatric chronic myeloid leukemia in pediatric chronic myeloid leukemia
Krumbhold M et al. Mol Cancer, Sept 2024 – open access publication

 

 

 

 

  1. CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast crisis (Kramp LJ et al. Ann Hematol, Sept 2024)
  2. Low-level BCR::ABL1 transcript at diagnosis in childhood leukemia: A 10-year single institution study (Cain LE et al. Genes Chromosomes Cancer, Sept 2024)
  3. Chronic myeloid leukemia in adolescents and young adults Clinicopathological variables and outcomes (Abdulla MA et al. Oncology, July 2024)
  4. Impact of tyrosine kinase inhibitors (TKIs) on growth in children and adolescents with CML: A systematic review (Katsarou D et al., Curr Pharm Des, July 2024)